This study suggests that CBD induces pyroptosis in liver cancer cells in a caspase-3/gasdermin E (GSDME)-dependent manner and can inhibit aerobic glycolysis by regulating the ATF4-IGFBP1-Akt axis [44]. This evidence concerns the gene AKT1 and liver cancer.